IndianaChristianNews.com
About IndianaChristianNews.com
Acomplia (rimonabant) is an anti-obesity drug. Under development by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity. Both medical researchers and physicians accept Acomplia as a significant contribution to the range of treatments available to help people with weight loss and to reduce the risks of illness and disease caused by carrying excessive weight.
